Senvest Management’s Doximity DOCS Stock Holding History

Senvest Management’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,700	Closed	-$296K	–	59
2026 Q1	$296K	Buy	+12,700	New	+$396K	0.01%	50

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Senvest Management's DOCS Position: Q2 2026 in Review

Senvest Management sold out of Doximity (DOCS) in Q2 2026, closing a stake of 12,700 shares — an estimated $296K sold.

Senvest Management first reported a position in DOCS in Q1 2026 and held it in 1 quarter. The position peaked at $296K in Q1 2026. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

Senvest Management reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
Senvest Management sold 12,700 Doximity shares in Q2 2026, an estimated $296K.
Senvest Management first reported a position in Doximity in Q1 2026 and held it in 1 quarter.
Senvest Management's Doximity position peaked at $296K in Q1 2026.
358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Senvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.